A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort study.

Saved in:
Bibliographic Details
Title: A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort study.
Authors: Islam SS; Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. sislam83@kfshrc.edu.sa.; School of Medicine, Al-Faisal University, Riyadh, Saudi Arabia. sislam83@kfshrc.edu.sa., Al-Tweigeri T; Department of Breast Oncology, Cancer Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Tulbah A; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Najjar SN; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Aljohani SS; Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Al-Harbi L; Department of Infection and Immunity, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Gad AM; Department of Breast Oncology, Cancer Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Ujjahan S; Department of Radiation Oncology, Chattogram Maa-O-Sishu Hospital, and Park View Hospital, Chattogram, Bangladesh., Aboussekhra A; Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Source: Cell death discovery [Cell Death Discov] 2025 Sep 09; Vol. 11 (1), pp. 421. Date of Electronic Publication: 2025 Sep 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2058-7716
DOI:10.1038/s41420-025-02701-8